StockData
Alpha Teknova, Inc. logo

Alpha Teknova, Inc. (TKNO) stock

TKNONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/30150% above fair value
$8.29−0.32 (-3.77%)

Close on Nov 12, 2026Market cap $445.34MP/E –Yield –

Alpha Teknova gross margin

Gross margin is gross profit as a percentage of revenue.

Alpha Teknova's gross margin for the twelve months ending Sep 30, 2026 was 36.4%. For fiscal 2025 it was 33.2%, against 19.2% the year before. The highest annual figure on record is 56.7% in fiscal 2020.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202533.2%+14.0
FY2024Dec 31, 202419.2%−8.9
FY2023Dec 31, 202328.1%−14.1
FY2022Dec 31, 202242.2%−5.6
FY2021Dec 31, 202147.8%−9.0
FY2020Dec 31, 202056.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202638.0%+7.3
Q2 FY2026Jun 30, 202640.1%+1.4
Q1 FY2026Mar 31, 202634.2%+3.5
Q4 FY2025Dec 31, 202532.5%+9.5
Q3 FY2025Sep 30, 202530.7%+29.7
Q2 FY2025Jun 30, 202538.7%+9.6
Q1 FY2025Mar 31, 202530.7%+6.9
Q4 FY2024Dec 31, 202423.0%+6.0
Q3 FY2024Sep 30, 20240.9%−17.1
Q2 FY2024Jun 30, 202429.2%−14.8
Q1 FY2024Mar 31, 202423.8%−2.8
Q4 FY2023Dec 31, 202317.0%−9.8
Q3 FY2023Sep 30, 202318.0%−26.6
Q2 FY2023Jun 30, 202343.9%−0.9
Q1 FY2023Mar 31, 202326.6%−21.4
Q4 FY2022Dec 31, 202226.7%−22.5
Q3 FY2022Sep 30, 202244.6%−0.8
Q2 FY2022Jun 30, 202244.9%+4.5
Q1 FY2022Mar 31, 202248.0%−7.4
Q4 FY2021Dec 31, 202149.2%−5.6
Q3 FY2021Sep 30, 202145.4%−11.2
Q2 FY2021Jun 30, 202140.3%−17.0
Q1 FY2021Mar 31, 202155.4%–
Q4 FY2020Dec 31, 202054.8%–
Q3 FY2020Sep 30, 202056.6%–
Q2 FY2020Jun 30, 202057.4%–

More Alpha Teknova figures

See a number that looks wrong?